Lilly Clashes With Valeant Over Permax Liability Costs

By Samuel Howard · December 29, 2008, 12:00 AM EST

As Eli Lilly and Co. faces product liability claims over its discontinued drug Permax, the drugmaker has sued Valeant Pharmaceuticals International to force the bridling licensee to shoulder its share of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

ELI LILLY AND COMPANY v. VALEANT PHARMACEUTICALS INTERNATIONAL

Case Number

Court

Indiana Southern

Nature of Suit

195(Contract Product Liability)

Date Filed

December 24, 2008

Recent Articles By Samuel

February 08, 2012
PE's Healing Touch Faces Test In Hospital Buys
January 25, 2012
Planned Parenthood Buys NY Headquarters For $35M
January 05, 2012
Schein Buys Oak Hill's Stake In Vet Supply Unit For $155M
November 21, 2011
PE Firm Ratos Sells 2 Cos. To 3D Systems For $137M
November 21, 2011
Valeant Buys INova From PE Firms For $688M
November 08, 2011
Goodwin Helps TA Snag Senior Whole Health For $135M
November 01, 2011
Hogan Lovells Guides Glucose Tester In $54M Fundraising
October 20, 2011
VC Firm Pursues Massive $250M Hospital Project In Texas
October 13, 2011
Centurion Shores Up Biotech Outfit With $10M Investment
October 07, 2011
Simpson, Kirkland Aid Investors In $1.6B KCI Notes Deal